Patents by Inventor F. Eugene Harrington

F. Eugene Harrington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of acne or of pseudofolliculitis barbae
    Patent number: 5328686
    Abstract: Patients suffering from acne and/or pseudofolliculitis barbae are treated by applying to the skin of the patient an inhibitor of ornithine decarboxylase.
    Type: Grant
    Filed: October 30, 1991
    Date of Patent: July 12, 1994
    Inventors: Douglas Shander, F. Eugene Harrington, Mary C. Whitmore
  • Enzymic alteration of hair growth
    Patent number: 5132293
    Abstract: The rate and character of mammalian hair growth is altered by topical application to the skin of a composition containing a dermatologically acceptable carrier and an inhibitor of S-adenosylmethionine decarboxylase with or without an ornithine decarboxylase inhibitor.
    Type: Grant
    Filed: October 28, 1991
    Date of Patent: July 21, 1992
    Inventors: Douglas Shander, F. Eugene Harrington, Gurpreet S. Ahluwalia
  • Alteration of rate and character of hair growth
    Patent number: 5096911
    Abstract: The rate and character of mammalian hair growth is altered by the topical application to the skin of a composition containing an inhibitor of the enzyme gamma- glutamyl transpeptidase.
    Type: Grant
    Filed: June 25, 1990
    Date of Patent: March 17, 1992
    Inventors: Gurpreet S. Ahluwalia, Douglas Shander, F. Eugene Harrington
  • Method of inhibiting prolactin secretion
    Patent number: 4287196
    Abstract: Certain known pyrimido[2,1-a]isoindoles and diazepino[2,1-a]isoindoles, e.g., 7-(p-chlorophenyl)-7-hydroxy-2,3,4,5-tetrahydro-7H-[1,3]-diazepino[2,1-a]i soindoles, are useful for inhibiting prolactin secretion.
    Type: Grant
    Filed: February 26, 1980
    Date of Patent: September 1, 1981
    Assignee: Sandoz, Inc.
    Inventors: Ronald G. Babington, F. Eugene Harrington, William J. Houlihan
  • Prolactin secretion inhibitors
    Patent number: 4202897
    Abstract: Certain known imidazo[2,1-a]isoindoles and isoquinolines, e.g., 5-(p-chlorophenyl)-5-hydroxy-2,3-dihydro-5H-imidazo[2,1-a]isoindole (mazindol), have been found to be useful as inhibitors of prolactin secretion, and may be so utilized alone or as an agent which enhances the action of other chemical compounds having activity in inhibiting prolactin secretion.
    Type: Grant
    Filed: May 11, 1978
    Date of Patent: May 13, 1980
    Assignee: Sandoz, Inc.
    Inventors: Ronald G. Babington, F. Eugene Harrington